tiprankstipranks
Clearside Biomedical (CLSD)
NASDAQ:CLSD
US Market

Clearside Biomedical (CLSD) Income Statement

Compare
1,005 Followers

Clearside Biomedical Income Statement

Last quarter (Q3 2024), Clearside Biomedical's total revenue was $1.04M, an increase of 20.84% from the same quarter last year. In Q3, Clearside Biomedical's net income was $-7.69M. See Clearside Biomedical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 8.23M$ 1.33M$ 29.57M$ 7.89M$ 2.17M
Gross Profit
$ 7.87M$ 1.12M$ 29.40M$ 7.89M$ 2.17M
Operating Expenses
$ 32.72M$ 31.40M$ 30.20M$ 25.83M$ 32.48M
Depreciation and Amortization
$ 67.00K$ 145.00K$ 178.00K$ 180.00K$ 211.00K
EBITDA
$ -23.06M$ -29.46M$ -449.00K$ -17.93M$ -30.09M
Operating Income
$ -24.84M$ -30.28M$ -627.00K$ -17.93M$ -30.30M
Other Income/Expenses
$ -7.64M$ -2.67M$ 1.00M$ -275.00K$ -466.00K
Pretax Income
$ -32.48M$ -32.95M$ 376.00K$ -18.21M$ -30.77M
Net Income
$ -32.48M$ -34.07M$ 376.00K$ -18.03M$ -30.56M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.53$ -0.57$ 0.01$ -0.39$ -0.80
Diluted EPS
$ -0.53$ -0.57$ 0.01$ -0.39$ -0.80
Weighted Average Shares Outstanding
61.81M 60.20M 58.49M 46.51M 38.17M
Weighted Average Shares Outstanding (Diluted)
61.81M 60.20M 59.91M 46.51M 38.17M
Currency in USD

Clearside Biomedical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis